Purified poloxamer 188: QT/QTc study started

Adventrx began a 4-way crossover, double-blind, placebo- and active-controlled thorough QT/QTc trial to evaluate 2 doses of ANX-188 in about 60 healthy volunteers. ANX-188 is in the Phase III EPIC tri...